COVID-19 and reactions in the Norwegian population

Publications 2026

Semenchuk J, Naito Y, Charman SC, Carr SB, Duckers J, Cheng SY, Marshall BC, Faro A, Elbert A, Goss CH, Burgel PR, Colombo C, Salvatore M, Kashirskaya N, Kirwan L, Middleton PG, Naehrlich L, Pastor-Vivero MD, Jung A, Bakkeheim E, Zolin A, Orenti A, Zomer-van Ommen DD, Zampoli M, Stephenson AL et al. (2026)
Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population
J Cyst Fibros (in press)
DOI 10.1016/j.jcf.2026.02.009, PubMed 41820127

Kildal AB, Ueland T, Mirlashari MR, Nissen-Meyer LS, Granerud BK, Dyrhol-Riise AM, Tonby K, Holten AR, Heggelund L, Müller KE, Tveita A, Bøe S, Fagerhol MK, Hetland G, Holter JC, Norwegian SARS-CoV-2 study group (2026)
Serial blood serum measurements of calprotectin and deoxyribonuclease in COVID-19 patients during hospitalization and recovery until one year: a prospective, multicenter, observational study
BMC Infect Dis (in press)
DOI 10.1186/s12879-026-12939-x, PubMed 41772481

Otterdal K, Ueland T, Holter JC, Kaarbø M, Schanke Y, Granerud BK, Dahl TB, Tveita A, Kildal AB, Heggelund L, Aamodt AH, Holten AR, Tonby K, Aukrust P, Dyrhol-Riise AM, Halvorsen B, Michelsen AE (2026)
Platelet-derived mediators in hospitalized COVID-19 patients and associations to respiratory failure, ICU admittance and 60-day mortality
Front Cardiovasc Med, 13, 1685861
DOI 10.3389/fcvm.2026.1685861, PubMed 41822455